Preferential brain locations of low-grade gliomas, Cancer, vol.991, issue.12, pp.2622-2626, 2004. ,
DOI : 10.1212/WNL.46.2.508
Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas, Annals of Neurology, vol.22, issue.3, pp.380-383, 2006. ,
DOI : 10.1016/S0360-3016(01)02720-1
URL : https://hal.archives-ouvertes.fr/inserm-00163977
The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas, Cancer, vol.35, issue.6, pp.1784-1791, 1994. ,
DOI : 10.1016/0360-3016(77)90045-1
Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas, Journal of Clinical Oncology, vol.26, issue.8, pp.1338-1345, 2008. ,
DOI : 10.1200/JCO.2007.13.9337
Guidelines on management of low-grade gliomas: report of an EFNS-EANO* Task Force, European Journal of Neurology, vol.27, issue.9, pp.1124-1133, 2010. ,
DOI : 10.1200/JCO.2008.20.5765
Radical surgery after chemotherapy: a new therapeutic strategy to envision in grade II glioma, Journal of Neuro-Oncology, vol.6, issue.2, pp.171-176, 2006. ,
DOI : 10.1007/s11060-006-9168-3
Preoperative Chemotherapy for Infiltrative Low-Grade Oligoastrocytoma: a Useful Strategy to Maximize Surgical Resection, Neurologia medico-chirurgica, vol.50, issue.5, pp.410-413, 2010. ,
DOI : 10.2176/nmc.50.410
Combination of neoadjuvant chemotherapy followed by surgical resection as a new strategy for WHO grade II gliomas: a study of cognitive status and quality of life, Journal of Neuro-Oncology, vol.6, issue.2, 2011. ,
DOI : 10.1037/h0054651
Computational modeling of the WHO grade II glioma dynamics: principles and applications to management paradigm, Neurosurgical Review, vol.20, issue.6, pp.263-269, 2008. ,
DOI : 10.1016/S0028-3770(05)83486-1
Continuous growth of mean tumor diameter in a subset of grade II gliomas, Annals of Neurology, vol.54, issue.4, pp.524-528, 2003. ,
DOI : 10.1212/WNL.54.7.1442
Pregnancy increases the growth rates of World Health Organization grade II gliomas, Ann Neurol, vol.67, pp.398-404, 2010. ,
Functional mapping-guided resection of low-grade gliomas, Clin Neurosurg, vol.42, pp.437-452, 1995. ,
Prognostic significance of imaging contrast enhancement for WHO grade II gliomas, Neuro-Oncology, vol.11, issue.2, pp.176-182, 2009. ,
DOI : 10.1016/j.surneu.2006.04.015
URL : https://hal.archives-ouvertes.fr/inserm-00349509
Intraoperative cortico???subcortical stimulations in surgery of low-grade gliomas, Expert Review of Neurotherapeutics, vol.12, issue.4, pp.473-485, 2005. ,
DOI : 10.1097/00001756-200107200-00023
Contribution of cortical and subcortical electrostimulation in brain glioma surgery: Methodological and functional considerations, Neurophysiologie Clinique/Clinical Neurophysiology, vol.37, issue.6, pp.373-382, 2007. ,
DOI : 10.1016/j.neucli.2007.09.003
Predicting lung cancer by detecting aberrant promoter methylation in sputum, Cancer Res, vol.60, pp.5954-5958, 2000. ,
Analysis of the IDH1 codon 132 mutation in brain tumors, Acta Neuropathologica, vol.6, issue.6, pp.597-602, 2008. ,
DOI : 10.1093/jnen/59.6.544
mutations in Japanese glioma patients, Cancer Science, vol.324, issue.10, pp.1996-1998, 2009. ,
DOI : 10.1016/B978-0-12-152827-0.50009-8
Dynamic history of low-grade gliomas before and after temozolomide treatment, Annals of Neurology, vol.15, issue.5, pp.484-490, 2007. ,
DOI : 10.1128/MCB.15.8.4249
Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomas. Neuro Oncol, 2010. ,
Inter- and intrapatients comparison of WHO grade II glioma kinetics before and after surgical resection, Neurosurgical Review, vol.26, issue.8, pp.91-96, 2010. ,
DOI : 10.1007/s10143-009-0229-x
URL : https://hal.archives-ouvertes.fr/hal-00492516
Extension of paralimbic low grade gliomas: toward an anatomical classification based on white matter invasion patterns, Journal of Neuro-Oncology, vol.12, issue.2, pp.179-185, 2006. ,
DOI : 10.1016/S0002-9440(10)64183-1
URL : https://hal.archives-ouvertes.fr/inserm-00147499
Glioma dissemination along the corticospinal tract, Journal of Neuro-Oncology, vol.39, issue.2, pp.239-240, 2005. ,
DOI : 10.1007/s11060-005-0378-x
Does post-lesional subcortical plasticity exist in the human brain?, Neuroscience Research, vol.65, issue.2, pp.131-135, 2009. ,
DOI : 10.1016/j.neures.2009.07.002
Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade Glioma, Journal of Clinical Oncology, vol.20, issue.8, pp.2076-2084, 2002. ,
DOI : 10.1200/JCO.2002.08.121
Chromosome 1p loss: A favorable prognostic factor in low-grade gliomas, Annals of Neurology, vol.22, issue.2, pp.322-326, 2005. ,
DOI : 10.1016/S0360-3016(01)02692-X
A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma, Cancer Research, vol.66, issue.20, pp.9852-9861, 2006. ,
DOI : 10.1158/0008-5472.CAN-06-1796
Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic Oligodendrogliomas, JNCI: Journal of the National Cancer Institute, vol.15, issue.19, pp.1473-1479, 1998. ,
DOI : 10.1200/JCO.1997.15.12.3423
Temozolomide for low-grade gliomas: Predictive impact of 1p/19q loss on response and outcome, Neurology, vol.68, issue.21, pp.1831-1836, 2007. ,
DOI : 10.1212/01.wnl.0000262034.26310.a2
IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas, Neurology, vol.75, issue.17, pp.1560-1566, 2011. ,
DOI : 10.1212/WNL.0b013e3181f96282
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas, Journal of Clinical Oncology, vol.27, issue.25, pp.4150-4154, 2009. ,
DOI : 10.1200/JCO.2009.21.9832
MGMT methylation: A marker of response to temozolomide in low-grade gliomas, Annals of Neurology, vol.97, issue.6, pp.740-743, 2006. ,
DOI : 10.1093/jnen/60.8.808
Preoperative Chemotherapy for Infiltrative Low-Grade Oligoastrocytoma: a Useful Strategy to Maximize Surgical Resection, Neurologia medico-chirurgica, vol.50, issue.5, pp.410-413, 2010. ,
DOI : 10.2176/nmc.50.410
Radical surgery after chemotherapy: a new therapeutic strategy to envision in grade II glioma, Journal of Neuro-Oncology, vol.6, issue.2, pp.171-176, 2006. ,
DOI : 10.1007/s11060-006-9168-3
Neoadjuvant temozolomide followed by complete resection of a 1p- and
19q-deleted anaplastic oligoastrocytoma: Case study, Neuro-Oncology, vol.7, issue.1, pp.97-100, 2005. ,
DOI : 10.1093/neuonc/5.2.128
Low-grade gliomas in older patients: a retrospective analysis of prognostic factors, Journal of Neuro-Oncology, vol.95, issue.3, pp.341-350, 2008. ,
DOI : 10.1093/jnen/62.2.111
French brain tumor data bank: Methodology and first results on 10,000 cases, Journal of Neuro-Oncology, vol.61, issue.2, pp.189-199, 2007. ,
DOI : 10.1093/jnen/61.3.215
French Brain Tumor DataBase (FBTDB): Five years histological results on 25 756 cases, Brain Pathol, 2010. ,
Evidence for the genesis of WHO grade II glioma in an asymptomatic young adult using repeated MRIs, Acta Neurochirurgica, vol.240, issue.3, pp.473-477, 2010. ,
DOI : 10.1016/j.jns.2005.09.008
Natural history of incidental world health organization grade II gliomas, Annals of Neurology, vol.62, issue.5, pp.727-733, 2010. ,
DOI : 10.1016/S0360-3016(01)02720-1
Continuous growth of mean tumor diameter in a subset of grade II gliomas, Annals of Neurology, vol.54, issue.4, pp.524-528, 2003. ,
DOI : 10.1212/WNL.54.7.1442
Extension of paralimbic low grade gliomas: toward an anatomical classification based on white matter invasion patterns, Journal of Neuro-Oncology, vol.12, issue.2, pp.179-185, 2006. ,
DOI : 10.1016/S0002-9440(10)64183-1
URL : https://hal.archives-ouvertes.fr/inserm-00147499
Glioma dissemination along the corticospinal tract, Journal of Neuro-Oncology, vol.39, issue.2, pp.239-240, 2005. ,
DOI : 10.1007/s11060-005-0378-x
Simulation of anisotropic growth of low-grade gliomas using diffusion tensor imaging, Magnetic Resonance in Medicine, vol.6, issue.3, pp.616-624, 2005. ,
DOI : 10.1016/S0002-9440(10)64183-1
Influence of pregnancy in the behavior of diffuse gliomas: clinical cases of a French glioma study group, Journal of Neurology, vol.65, issue.12, pp.2014-2020, 2009. ,
DOI : 10.1097/01.AOG.0000188061.14425.e2
Pregnancy increases the growth rates of World Health Organization grade II gliomas, Ann Neurol, vol.67, pp.398-404, 2010. ,
Preferential brain locations of low-grade gliomas, Cancer, vol.991, issue.12, pp.2622-2626, 2004. ,
DOI : 10.1212/WNL.46.2.508
Seizure characteristics and control following resection in 332 patients with low-grade gliomas, Journal of Neurosurgery, vol.26, issue.2, pp.227-235, 2008. ,
DOI : 10.1212/01.WNL.0000079374.78589.1B
Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis, International Journal of Radiation Oncology*Biology*Physics, vol.45, issue.4, pp.923-929, 1999. ,
DOI : 10.1016/S0360-3016(99)00284-9
Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade Glioma, Journal of Clinical Oncology, vol.20, issue.8, pp.2076-2084, 2002. ,
DOI : 10.1200/JCO.2002.08.121
Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas, Annals of Neurology, vol.22, issue.3, pp.380-383, 2006. ,
DOI : 10.1016/S0360-3016(01)02720-1
URL : https://hal.archives-ouvertes.fr/inserm-00163977
Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas, Journal of Clinical Oncology, vol.26, issue.8, pp.1338-1345, 2008. ,
DOI : 10.1200/JCO.2007.13.9337
Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System, Journal of Neurosurgery, vol.16, issue.2, pp.203-210, 2009. ,
DOI : 10.1016/0360-3016(90)90397-3
Low-grade gliomas in older patients, Cancer, vol.68, issue.17, pp.3969-3978, 2009. ,
DOI : 10.1212/WNL.56.5.618
Prognosis and patterns of care in elderly patients with glioma, Cancer, vol.23, issue.23, pp.5534-5540, 2009. ,
DOI : 10.1093/jnen/64.6.479
Equal care for the elderly with low-grade gliomas?, Neurology, vol.73, issue.24, pp.2056-2057, 2009. ,
DOI : 10.1212/WNL.0b013e3181c67882
Outcome in adult low-grade glioma: The impact of prognostic factors and treatment, Neurology, vol.69, issue.13, pp.1366-1373, 2007. ,
DOI : 10.1212/01.wnl.0000277271.47601.a1
Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic, Neuro-Oncology, vol.11, issue.4, pp.437-445, 2009. ,
DOI : 10.1200/JCO.2004.10.169
Diagnostic and prognostic markers in gliomas, Current Opinion in Oncology, vol.21, issue.6, pp.537-542, 2009. ,
DOI : 10.1097/CCO.0b013e32833065a7
Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma, Journal of Neuro-Oncology, vol.24, issue.3, pp.401-415, 2009. ,
DOI : 10.2214/ajr.175.1.1750207
D??limitation spatiale des oligodendrogliomes de bas grade, Neurochirurgie, vol.51, issue.3-4, pp.254-259, 2005. ,
DOI : 10.1016/S0028-3770(05)83486-1
Diffuse low-grade oligodendrogliomas extend beyond MRI-defined abnormalities, Neurology, vol.74, issue.21, pp.1724-1731, 2011. ,
DOI : 10.1212/WNL.0b013e3181e04264
Prognostic significance of imaging contrast enhancement for WHO grade II gliomas, Neuro-Oncology, vol.11, issue.2, pp.176-182, 2009. ,
DOI : 10.1016/j.surneu.2006.04.015
URL : https://hal.archives-ouvertes.fr/inserm-00349509
Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas, The Lancet Neurology, vol.9, issue.9, pp.906-920, 2010. ,
DOI : 10.1016/S1474-4422(10)70181-2
Role of the healthy hemisphere in recovery after resection of the supplementary motor area, Neurology, vol.62, issue.8, pp.1323-1332, 2004. ,
DOI : 10.1212/01.WNL.0000120547.83482.B1
URL : https://hal.archives-ouvertes.fr/hal-00349683
Correspondence between functional magnetic resonance imaging somatotopy and individual brain anatomy of the central region: comparison with intraoperative stimulation in patients with brain tumors, Journal of Neurosurgery, vol.195, issue.4, pp.589-598, 2000. ,
DOI : 10.3171/jns.1996.85.4.0608
Brain Hodotopy: From Esoteric Concept to Practical Surgical Applications, Neurosurgery, vol.60, issue.4, 2011. ,
DOI : 10.2217/fnl.10.21
Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging, AJNR Am J Neuroradiol, vol.24, pp.1989-1998, 2003. ,
Low-Grade Gliomas: Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging???Prediction of Patient Clinical Response, Radiology, vol.238, issue.2, pp.658-667, 2006. ,
DOI : 10.1148/radiol.2382042180
Gliomas: Predicting Time to Progression or Survival with Cerebral Blood Volume Measurements at Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging, Radiology, vol.247, issue.2, pp.490-498, 2008. ,
DOI : 10.1148/radiol.2472070898
Relative cerebral blood volume measurements of low-grade gliomas predict patient outcome in a multi-institution setting, European Journal of Radiology, vol.73, issue.2, pp.215-220, 2010. ,
DOI : 10.1016/j.ejrad.2008.11.005
Role of perfusion, vascular permeability and anatomic MR imaging in radiation therapy for gliomas], Bull Cancer, vol.97, pp.753-758, 2010. ,
Microvascular leakage and contrast enhancement as prognostic factors for recurrence in unfavorable low-grade gliomas, Journal of Neuro-Oncology, vol.178, issue.Suppl 7, pp.81-88, 2010. ,
DOI : 10.2214/ajr.178.3.1780711
Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas, NeuroImage, vol.23, issue.2, pp.454-461, 2004. ,
DOI : 10.1016/j.neuroimage.2004.06.022
Noninvasive evaluation of cerebral glioma grade by using multivoxel 3D proton MR spectroscopy, Magnetic Resonance Imaging, vol.29, issue.1, pp.25-31, 2011. ,
DOI : 10.1016/j.mri.2010.07.017
Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas, AJNR Am J Neuroradiol, vol.21, pp.659-665, 2000. ,
Proton magnetic resonance spectroscopy predicts proliferative activity in diffuse low-grade gliomas, Journal of Neuro-Oncology, vol.30, issue.6 suppl 19, pp.181-187, 2008. ,
DOI : 10.2214/ajr.171.6.9843274
Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy, British Journal of Cancer, vol.17, issue.4, pp.781-786, 2004. ,
DOI : 10.1200/JCO.1999.17.9.2762
Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy, British Journal of Cancer, vol.87, issue.12, pp.1854-1861, 2011. ,
DOI : 10.3171/jns.1997.87.4.0516
URL : https://hal.archives-ouvertes.fr/hal-01469461
Predictive value of multimodality MRI using conventional, perfusion, and spectroscopy MR in anaplastic transformation of low-grade oligodendrogliomas, Journal of Neuro-Oncology, vol.29, issue.1, pp.73-80, 2010. ,
DOI : 10.1093/jnen/61.3.215
Prognostic value of choline and creatine in WHO grade II gliomas, Neuroradiology, vol.19, issue.9, pp.759-767, 2008. ,
DOI : 10.1016/S0360-3016(96)00352-5
Advances in adults' gliomas biology, imaging and treatment], Bull Cancer, vol.97, pp.17-36, 2010. ,
Inter- and intrapatients comparison of WHO grade II glioma kinetics before and after surgical resection, Neurosurgical Review, vol.26, issue.8, pp.91-96, 2010. ,
DOI : 10.1007/s10143-009-0229-x
URL : https://hal.archives-ouvertes.fr/hal-00492516
Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomas. Neuro Oncol, 2010. ,
Dynamic history of low-grade gliomas before and after temozolomide treatment, Annals of Neurology, vol.15, issue.5, pp.484-490, 2007. ,
DOI : 10.1128/MCB.15.8.4249
A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma, Cancer Research, vol.66, issue.20, pp.9852-9861, 2006. ,
DOI : 10.1158/0008-5472.CAN-06-1796
Alterations of Chromosome Arms 1p and 19q as Predictors of Survival in Oligodendrogliomas, Astrocytomas, and Mixed Oligoastrocytomas, Journal of Clinical Oncology, vol.18, issue.3, pp.636-645, 2000. ,
DOI : 10.1200/JCO.2000.18.3.636
Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype, Oncogene, vol.18, issue.28, pp.4144-4152, 1999. ,
DOI : 10.1002/gcc.2870110307
Population-Based Studies on Incidence, Survival Rates, and Genetic Alterations in Astrocytic and Oligodendroglial Gliomas, Journal of Neuropathology & Experimental Neurology, vol.10, issue.6, pp.479-489, 2005. ,
DOI : 10.1093/carcin/16.6.1277
Chromosomal alterations in oligodendroglial tumours over multiple surgeries: is tumour progression associated with change in 1p/19q status?, Journal of Neuro-Oncology, vol.42, issue.3, pp.37-45, 2008. ,
DOI : 10.1016/S0002-9440(10)61702-6
Novel Molecular Stereotactic Biopsy Procedures Reveal Intratumoral Homogeneity of Loss of Heterozygosity of 1p/19q and TP53 Mutations in World Health Organization Grade II Gliomas, Journal of Neuropathology and Experimental Neurology, vol.107, issue.11, pp.1219-1228, 2009. ,
DOI : 10.1007/BF01405784
Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic Oligodendrogliomas, JNCI: Journal of the National Cancer Institute, vol.15, issue.19, pp.1473-1479, 1998. ,
DOI : 10.1200/JCO.1997.15.12.3423
Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas, Acta Neuropathologica, vol.103, issue.3, pp.267-275, 2002. ,
DOI : 10.1007/s004010100464
Current concepts in the evaluation and management of WHO grade II gliomas, Journal of Neuro-Oncology, vol.91, issue.1, pp.253-259, 2009. ,
DOI : 10.1016/S0360-3016(96)00352-5
Biology of gliomas]. Cancer Radiother, pp.663-668, 2008. ,
Chromosome 1p loss: A favorable prognostic factor in low-grade gliomas, Annals of Neurology, vol.22, issue.2, pp.322-326, 2005. ,
DOI : 10.1016/S0360-3016(01)02692-X
Temozolomide As Initial Treatment for Adults With Low-Grade Oligodendrogliomas or Oligoastrocytomas and Correlation With Chromosome 1p Deletions, Journal of Clinical Oncology, vol.22, issue.15, pp.3133-3138, 2004. ,
DOI : 10.1200/JCO.2004.10.169
Two types of chromosome 1p losses with opposite significance in gliomas, Annals of Neurology, vol.11, issue.3, pp.483-487, 2005. ,
DOI : 10.1093/jnen/64.1.10
URL : https://hal.archives-ouvertes.fr/inserm-00310519
All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2, Neurology, vol.74, issue.23, pp.1886-1890, 2010. ,
DOI : 10.1212/WNL.0b013e3181e1cf3a
??-Internexin expression identifies 1p19q codeleted gliomas, Neurology, vol.72, issue.2, pp.156-161, 2009. ,
DOI : 10.1212/01.wnl.0000339055.64476.cb
Lack of complete 1p19q deletion in a consecutive series of 12 WHO grade II gliomas involving the insula: a marker of worse prognosis?, Journal of Neuro-Oncology, vol.58, issue.3, pp.1-5, 2009. ,
DOI : 10.1016/S0002-9440(10)64183-1
Chromosome 9p and 10q losses predict unfavorable outcome in low-grade gliomas, Neuro-Oncology, vol.88, issue.3, pp.2-6, 2010. ,
DOI : 10.1007/s11060-008-9563-z
Molecular Markers in Low-Grade Gliomas: Predictive or Prognostic? Clin Cancer Res, pp.4588-4599, 2011. ,
O6-methylguanine-DNA methyltransferase methylation andTP53 mutation in malignant astrocytomas and their relationships with clinical course, International Journal of Cancer, vol.52, issue.4, pp.581-587, 2005. ,
DOI : 10.1016/S0027-5107(00)00022-1
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas, Acta Neuropathologica, vol.324, issue.2, pp.469-474, 2009. ,
DOI : 10.1007/BF00284430
Mutations in Gliomas, New England Journal of Medicine, vol.360, issue.8, pp.765-773, 2009. ,
DOI : 10.1056/NEJMoa0808710
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas, Journal of Clinical Oncology, vol.27, issue.25, pp.4150-4154, 2009. ,
DOI : 10.1200/JCO.2009.21.9832
IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas, The American Journal of Pathology, vol.174, issue.4, pp.1149-1153, 2009. ,
DOI : 10.2353/ajpath.2009.080958
MGMT methylation: A marker of response to temozolomide in low-grade gliomas, Annals of Neurology, vol.97, issue.6, pp.740-743, 2006. ,
DOI : 10.1093/jnen/60.8.808
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, The Lancet Oncology, vol.10, issue.5, pp.459-466, 2009. ,
DOI : 10.1016/S1470-2045(09)70025-7
gene in oligodendroglial tumors, International Journal of Cancer, vol.188, issue.3, pp.379-385, 2005. ,
DOI : 10.1016/S0304-3835(02)00198-2
Progressive low-grade oligodendrogliomas, Cancer, vol.68, issue.8, pp.1759-1765, 2006. ,
DOI : 10.1093/jnen/63.4.314
-methylguanine DNA methyltransferase (MGMT), p53 and Ki-67 in diffuse gliomas of World Health Organization (WHO) grades II and III: a clinicopathological study, Neuropathology and Applied Neurobiology, vol.31, issue.4, pp.367-379, 2009. ,
DOI : 10.1212/01.WNL.0000148642.26985.68
Longitudinal Assessment of Genetic and Epigenetic Markers in Oligodendrogliomas, Clinical Cancer Research, vol.13, issue.5, pp.1429-1437, 2007. ,
DOI : 10.1158/1078-0432.CCR-06-2050
IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas, Neurology, vol.75, issue.17, pp.1560-1566, 2011. ,
DOI : 10.1212/WNL.0b013e3181f96282
Phase II Study of Protracted Daily Temozolomide for Low-Grade Gliomas in Adults, Clinical Cancer Research, vol.15, issue.1, pp.330-337, 2009. ,
DOI : 10.1158/1078-0432.CCR-08-0888
Promoter Hypermethylation of the DNA Repair Gene O6-Methylguanine-DNA Methyltransferase is an Independent Predictor of Shortened Progression Free Survival in Patients with Low-grade Diffuse Astrocytomas, Brain Pathology, vol.16, issue.2, pp.176-184, 2003. ,
DOI : 10.1093/jnen/60.12.1181
Glioma-derived mutations in IDH: From mechanism to potential therapy, Biochemical and Biophysical Research Communications, vol.397, issue.2, pp.127-130, 2010. ,
DOI : 10.1016/j.bbrc.2010.05.115
An Integrated Genomic Analysis of Human Glioblastoma Multiforme, Science, vol.25, issue.13, pp.1807-1812, 2008. ,
DOI : 10.1002/jcc.20084
Monoclonal antibody specific for IDH1 R132H mutation, Acta Neuropathologica, vol.324, issue.5, pp.599-601, 2009. ,
DOI : 10.1007/s00401-009-0595-z
Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology, Acta Neuropathologica, vol.360, issue.2, pp.241-252, 2011. ,
DOI : 10.1056/NEJMoa0808710
The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas, Cancer, vol.35, issue.6, pp.1784-1791, 1994. ,
DOI : 10.1016/0360-3016(77)90045-1
GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME, Neurosurgery, vol.78, issue.4, pp.753-764, 2008. ,
DOI : 10.1259/bjr/28534346
Operative techniques for gliomas and the value of extent of resection, Neurotherapeutics, vol.62, issue.3, pp.478-486, 2009. ,
DOI : 10.1227/01.neu.0000317304.31579.17
Long-term outcome and survival of surgically treated supratentorial low-grade glioma in adult patients, Acta Neurochirurgica, vol.151, issue.11, pp.1359-1365, 2009. ,
DOI : 10.1007/s00701-009-0473-4
Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial, Journal of Neurosurgery, vol.16, issue.98, pp.835-841, 2008. ,
DOI : 10.1016/S0140-6736(05)67070-5
Preoperative estimation of residual volume for WHO grade II glioma resected with intraoperative functional mapping, Neuro-Oncology, vol.9, issue.1, pp.63-69, 2007. ,
DOI : 10.1259/bjr/28534346
URL : https://hal.archives-ouvertes.fr/inserm-00164361
Intraoperative stimulation techniques for functional pathway preservation and glioma resection, Neurosurgical Focus, vol.69, issue.2, p.1, 2010. ,
DOI : 10.1259/bjr/28534346
Awake Surgery for Nonlanguage Mapping, Neurosurgery, vol.7, issue.6, pp.523-528, 2010. ,
DOI : 10.1212/WNL.57.5.871
Intraoperative subcortical stimulation mapping of language pathways in a consecutive series of 115 patients with Grade II glioma in the left dominant hemisphere, Journal of Neurosurgery, vol.51, issue.1, pp.461-471, 2008. ,
DOI : 10.1016/j.ejrad.2005.04.010
Usefulness of intraoperative electrical subcortical mapping during surgery for low-grade gliomas located within eloquent brain regions: functional results in a consecutive series of 103 patients, Journal of Neurosurgery, vol.195, issue.4, pp.764-778, 2003. ,
DOI : 10.3171/jns.1996.85.4.0542
Contribution of intraoperative electrical stimulations in surgery of low grade gliomas: a comparative study between two series without (1985-96) and with (1996-2003) functional mapping in the same institution, Journal of Neurology, Neurosurgery & Psychiatry, vol.76, issue.6, pp.845-851, 2005. ,
DOI : 10.1136/jnnp.2004.048520
Guidelines on management of low-grade gliomas: report of an EFNS-EANO* Task Force, European Journal of Neurology, vol.27, issue.9, pp.1124-1133, 2010. ,
DOI : 10.1200/JCO.2008.20.5765
Functional mapping???guided resection of low-grade gliomas in eloquent areas of the brain: improvement of long-term survival, Journal of Neurosurgery, vol.42, issue.3, pp.566-573, 2011. ,
DOI : 10.1016/S0140-6736(05)67070-5
Re-operation is a safe and effective therapeutic strategy in recurrent WHO grade II gliomas within eloquent areas, Acta Neurochirurgica, vol.78, issue.5, pp.427-436, 2009. ,
DOI : 10.1093/jnen/61.3.215
Combined multiple surgical intervention and chemotherapy for multicentric WHO grade II glioma, Acta Neurochirurgica, vol.68, issue.12, pp.1699-1704, 2009. ,
DOI : 10.1016/S0035-3787(06)75088-3
Awake surgery for WHO Grade II gliomas within ???noneloquent??? areas in the left dominant hemisphere: toward a ???supratotal??? resection, Journal of Neurosurgery, vol.56, issue.2, 2011. ,
DOI : 10.1016/j.neuroimage.2005.11.002
Resection of World Health Organization Grade Ii Gliomas Involving Broca's Area: Methodological and Functional Considerations, Neurosurgery, vol.78, issue.4, pp.741-752, 2007. ,
DOI : 10.1259/bjr/28534346
A personal consecutive series of surgically treated 51 cases of insular WHO Grade II glioma: advances and limitations, Journal of Neurosurgery, vol.4, issue.4, pp.696-708, 2009. ,
DOI : 10.3171/jns.1996.85.2.0263
Cognitive Rehabilitation in Patients With Gliomas: A Randomized, Controlled Trial, Journal of Clinical Oncology, vol.27, issue.22, pp.3712-3722, 2009. ,
DOI : 10.1200/JCO.2008.20.5765
A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) study 22844, International Journal of Radiation Oncology*Biology*Physics, vol.36, issue.3, pp.549-556, 1996. ,
DOI : 10.1016/S0360-3016(96)00352-5
Prospective Randomized Trial of Low- Versus High-Dose Radiation Therapy in Adults With Supratentorial Low-Grade Glioma: Initial Report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group Study, Journal of Clinical Oncology, vol.20, issue.9, pp.2267-2276, 2002. ,
DOI : 10.1200/JCO.2002.09.126
Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised Phase III trial on dose response (EORTC trial 22844), European Journal of Cancer, vol.34, issue.12, pp.1902-1909, 1998. ,
DOI : 10.1016/S0959-8049(98)00268-8
Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial, The Lancet, vol.366, issue.9490, pp.985-990, 2005. ,
DOI : 10.1016/S0140-6736(05)67070-5
Final report of Radiation Therapy Oncology Group (RTOG) protocol 9802: Radiation therapy (RT) versus RT + procarbazine, CCNU, and vincristine (PCV) chemotherapy for adult low-grade glioma (LGG), Journal of Clinical Oncology, vol.26, issue.15_suppl, 2008. ,
DOI : 10.1200/jco.2008.26.15_suppl.2006
Sofortige postoperative Strahlentherapie oder abwartende Haltung bei der Behandlung niedrigmaligner Gliome im Erwachsenenalter?, Strahlentherapie und Onkologie, vol.180, issue.7, pp.408-418, 2004. ,
DOI : 10.1007/s00066-004-1221-6
Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up, The Lancet Neurology, vol.8, issue.9, pp.810-818, 2009. ,
DOI : 10.1016/S1474-4422(09)70204-2
Delayed Radiation Toxicity after Focal or Whole Brain Radiotherapy for Low-Grade Glioma, Journal of Neuro-Oncology, vol.66, issue.3, pp.333-339, 2004. ,
DOI : 10.1023/B:NEON.0000014518.16481.7e
Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma, Neurology, vol.59, issue.1, pp.121-123, 2002. ,
DOI : 10.1212/WNL.59.1.121
Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study, The Lancet, vol.360, issue.9343, pp.1361-1368, 2002. ,
DOI : 10.1016/S0140-6736(02)11398-5
Endocrine functions in long-term survivors of low-grade supratentorial glioma treated with radiation therapy, Journal of Neuro-Oncology, vol.123, issue.2, pp.97-102, 1995. ,
DOI : 10.1111/j.1651-2227.1989.tb11249.x
A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas: a Southwest Oncology Group study, Journal of Neurosurgery, vol.18, issue.6, pp.909-914, 1993. ,
DOI : 10.3171/jns.1989.71.4.0487
Successful chemotherapy for newly diagnosed aggressive oligodendroglioma, Annals of Neurology, vol.59, issue.5, pp.573-574, 1990. ,
DOI : 10.1002/ana.410270519
Low-grade oligodendroglioma responds to chemotherapy, Neurology, vol.46, issue.1, pp.203-207, 1996. ,
DOI : 10.1212/WNL.46.1.203
PCV Chemotherapy for Recurrent Oligodendrogliomas and Oligoastrocytomas, Neurosurgery, vol.68, issue.5, pp.1066-1073, 1998. ,
DOI : 10.3171/jns.1988.68.5.0684
Phase II Trial of Procarbazine, Lomustine, and Vincristine as Initial Therapy for Patients With Low-Grade Oligodendroglioma or Oligoastrocytoma: Efficacy and Associations With Chromosomal Abnormalities, Journal of Clinical Oncology, vol.21, issue.2, pp.251-255, 2003. ,
DOI : 10.1200/JCO.2003.06.023
Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine, Cancer, vol.52, issue.4, pp.802-809, 2005. ,
DOI : 10.1016/S0167-8140(96)91782-X
Treatment of newly diagnosed symptomatic pure lowgrade oligodendrogliomas with PCV chemotherapy Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group, Eur J Neurol. Neurology, vol.1451, issue.127, pp.391-3981140, 1998. ,
Neurotoxicity of combination chemotherapy with procarbazine, CCNU and vincristine (PCV) for recurrent glioma, Journal of Neuro-Oncology, vol.38, issue.1, pp.69-75, 1998. ,
DOI : 10.1023/A:1005909318270
Retrospective analysis of treatment outcome in 315 patients with oligodendroglial brain tumors, BMC Neurology, vol.31, issue.1, p.33, 2009. ,
DOI : 10.1053/j.seminoncol.2004.07.006
Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas, Annals of Oncology, vol.14, issue.12, pp.1715-1721, 2003. ,
DOI : 10.1093/annonc/mdg371
Phase II Trial of Temozolomide in Patients With Progressive Low-Grade Glioma, Journal of Clinical Oncology, vol.21, issue.4, pp.646-651, 2003. ,
DOI : 10.1200/JCO.2003.01.009
Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response, Annals of Oncology, vol.14, issue.12, pp.1722-1726, 2003. ,
DOI : 10.1093/annonc/mdg502
Phase II Study of First-Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors: The European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971, Journal of Clinical Oncology, vol.21, issue.13, pp.2525-2528, 2003. ,
DOI : 10.1200/JCO.2003.12.015
Temozolomide for low-grade gliomas: Predictive impact of 1p/19q loss on response and outcome, Neurology, vol.68, issue.21, pp.1831-1836, 2007. ,
DOI : 10.1212/01.wnl.0000262034.26310.a2
Phase I trial of temozolomide using an extended continuous oral schedule, Cancer Res, vol.58, pp.4363-4367, 1998. ,
Early metabolic responses in temozolomide treated low-grade glioma patients, Journal of Neuro-Oncology, vol.67, issue.1, pp.87-93, 2009. ,
DOI : 10.1097/nen.0b013e31815f65fb
Toxicity and efficacy of protracted low dose temozolomide for the treatment of low grade gliomas, Journal of Neuro-Oncology, vol.52, issue.3, pp.281-288, 2007. ,
DOI : 10.1179/joc.2005.17.6.674
Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas, Journal of Neuro-Oncology, vol.13, issue.2, pp.179-185, 2008. ,
DOI : 10.1111/j.1750-3639.2003.tb00017.x
Combination of neoadjuvant chemotherapy followed by surgical resection as a new strategy for WHO grade II gliomas: a study of cognitive status and quality of life, Journal of Neuro-Oncology, vol.6, issue.2, 2011. ,
DOI : 10.1037/h0054651
Long-term outcome of low-grade oligodendroglioma and mixed glioma, Neurology, vol.54, issue.7, pp.1442-1448, 2000. ,
DOI : 10.1212/WNL.54.7.1442
Brain plasticity: From pathophysiological mechanisms to therapeutic applications, Journal of Clinical Neuroscience, vol.13, issue.9, pp.885-897, 2006. ,
DOI : 10.1016/j.jocn.2005.11.045
URL : https://hal.archives-ouvertes.fr/inserm-00163803
Secondary Ph+ acute lymphoblastic leukemia after temozolomide, Annals of Hematology, vol.33, issue.4, pp.760-762, 2005. ,
DOI : 10.1007/s00277-005-1093-6
Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma, Journal of Clinical Neuroscience, vol.16, issue.4, pp.591-592, 2009. ,
DOI : 10.1016/j.jocn.2008.05.030
Hematologic adverse events associated with temozolomide, Cancer Chemotherapy and Pharmacology, vol.45, issue.1, 2011. ,
DOI : 10.1136/jmg.2007.053850
Acute lymphoblastic leukemia subsequent to temozolomide use in a 26-year-old man: a case report, Journal of Medical Case Reports, vol.107, issue.1, p.274, 2010. ,
DOI : 10.1182/blood-2005-09-3649
Unexpected case of aplastic anemia in a patient with glioblastoma multiforme treated with Temozolomide, Journal of Neuro-Oncology, vol.91, issue.1, pp.105-107, 2007. ,
DOI : 10.1007/s11060-007-9398-z
Treatment-related myelodysplasia/AML in a patient with a history of breast cancer and an oligodendroglioma treated with temozolomide: Case study and review of the literature1, Neuro-Oncology, vol.8, issue.3, pp.280-283, 2006. ,
DOI : 10.1007/s11060-004-2028-0
Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma, Journal of Neuro-Oncology, vol.43, issue.6, pp.315-318, 2005. ,
DOI : 10.1007/s11060-004-2028-0
Bone marrow transplantation for severe aplastic anemia secondary to temozolomide, Journal of Neuro-Oncology, vol.7, issue.5, pp.237-239, 2009. ,
DOI : 10.1007/s11060-008-9704-4
An Unusual Case of Aplastic Anemia Caused by Temozolomide, Case Reports in Medicine, vol.23, issue.1546, p.975039, 2010. ,
DOI : 10.1016/S1470-2045(06)70696-9
Non-Hodgkin lymphoma following temozolomide, Pediatric Blood & Cancer, vol.91, issue.4, pp.661-662, 2009. ,
DOI : 10.1002/pbc.22090
Aplastic anaemia in patient with glioblastoma multiforme treated with temozolomide, The Lancet Oncology, vol.7, issue.5, pp.436-438, 2006. ,
DOI : 10.1016/S1470-2045(06)70696-9
Phase II imatinib + hydroxyurea in treatment of patients with recurrent/progressive grade II low-grade glioma (LGG), 2009. ,
Effects of Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma Measured by the Folstein Mini-Mental State Examination, Journal of Clinical Oncology, vol.21, issue.13, pp.2519-2524, 2003. ,
DOI : 10.1200/JCO.2003.04.172
Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma, International Journal of Radiation Oncology*Biology*Physics, vol.59, issue.1, pp.117-125, 2004. ,
DOI : 10.1016/j.ijrobp.2003.10.040
The Measurement of Cognitive Functioning in Low-Grade Glioma Patients After Radiotherapy, Journal of Clinical Oncology, vol.22, issue.5, pp.966-967, 2004. ,
DOI : 10.1200/JCO.2004.99.290
Multifaceted end points in brain tumor clinical trials: Cognitive
deterioration precedes MRI progression, Neuro-Oncology, vol.5, issue.2, pp.89-95, 2003. ,
DOI : 10.1002/1097-0142(19950301)75:5<1151::AID-CNCR2820750515>3.0.CO;2-Q
The neurocognitive effects of radiation in adult low-grade glioma
patients, Neuro-Oncology, vol.5, issue.3, pp.161-167, 2003. ,
DOI : 10.1007/BF01476278
Late cognitive and radiographic changes related to radiotherapy: Initial prospective findings, Neurology, vol.59, issue.1, pp.40-48, 2002. ,
DOI : 10.1212/WNL.59.1.40
Cognitive function after radiotherapy for supratentorial low-grade glioma: A North Central Cancer Treatment Group prospective study, International Journal of Radiation Oncology*Biology*Physics, vol.63, issue.4, pp.1175-1183, 2005. ,
DOI : 10.1016/j.ijrobp.2005.04.016
Cognitive Deficits before Treatment among Patients with Brain Tumors, Neurosurgery, vol.22, issue.2, pp.324-333, 2000. ,
DOI : 10.1227/00006123-198805000-00012
Neurocognitive sequelae in the treatment of low-grade gliomas, Seminars in Oncology, vol.30, pp.45-48, 2003. ,
DOI : 10.1053/j.seminoncol.2003.11.023
Impaired cognitive functioning in low-grade glioma patients: relationship to tumor localisation, radiotherapy and the use of anticonvulsants], Ned Tijdschr Geneeskd, vol.148, pp.2175-2180, 2004. ,
Assessment of verbal working memory before and after surgery for low-grade glioma, Journal of Neuro-Oncology, vol.97, issue.3, pp.305-313, 2007. ,
DOI : 10.1007/s11060-006-9233-y
URL : https://hal.archives-ouvertes.fr/inserm-00164424
The Impact of Low-Grade Brain Tumors on Verbal Fluency Performance Bram Goldstein, Journal of Clinical and Experimental Neuropsychology, vol.26, issue.6, pp.750-758, 2004. ,
DOI : 10.1080/13803390490509376
Quality of life and neuropsychological functions in long-term low-grade glioma survivors, International Journal of Radiation Oncology*Biology*Physics, vol.29, issue.5, pp.1201-1202, 1994. ,
DOI : 10.1016/0360-3016(94)90423-5
Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas, Neurology, vol.56, issue.5, pp.618-623, 2001. ,
DOI : 10.1212/WNL.56.5.618
Early cognitive impairment in a subset of patients with presumed low-grade glioma, Neurocase, vol.15, issue.6, pp.503-511, 2010. ,
DOI : 10.1111/j.1600-0447.1983.tb09716.x
Health-related quality of life and cognitive functioning in adult patients with supratentorial WHO grade??II glioma: status prior to therapy, Journal of Neuro-Oncology, vol.27, issue.9, pp.129-136, 2011. ,
DOI : 10.1200/JCO.2008.20.5765
Therapeutic irradiation and brain injury, International Journal of Radiation Oncology*Biology*Physics, vol.6, issue.9, pp.1215-1228, 1980. ,
DOI : 10.1016/0360-3016(80)90175-3
Cognitive sequelae of brain tumor treatment, Current Opinion in Neurology, vol.18, issue.6, pp.662-666, 2005. ,
DOI : 10.1097/01.wco.0000191511.52745.99
Kognitive Leistungsf??higkeit von Erwachsenen nach Chemo- und/oder kranieller Strahlentherapie, Strahlentherapie und Onkologie, vol.181, issue.3, pp.141-156, 2005. ,
DOI : 10.1007/s00066-005-1351-5
Cognitive function after chemotherapy in adults with solid tumours, Critical Reviews in Oncology/Hematology, vol.63, issue.3, pp.183-202, 2007. ,
DOI : 10.1016/j.critrevonc.2007.06.001
Two year survival after malignant cerebral glioma: patient and relative reports of handicap, psychiatric symptoms and rehabilitation, Disability and Rehabilitation, vol.25, issue.6, pp.259-266, 2003. ,
DOI : 10.1080/0963828021000024915
A description of a cognitive rehabilitation programme evaluated in brain tumour patients with mild to moderate cognitive deficits, Clinical Rehabilitation, vol.10, issue.5, 2011. ,
DOI : 10.1016/j.brat.2009.01.010
Phase II Study of Donepezil in Irradiated Brain Tumor Patients: Effect on Cognitive Function, Mood, and Quality of Life, Journal of Clinical Oncology, vol.24, issue.9, pp.1415-1420, 2006. ,
DOI : 10.1200/JCO.2005.03.3001
Effects of methylphenidate versus sustained release methylphenidate on cognitive functioning, 418691. ,
Donepezil in treating patients who have undergone radiation therapy for brain tumors, p.369785 ,
Armodafinil in treating fatigue caused by radiation therapy in patients with primary brain tumors, 1032200. ,
Interstitial brachytherapy for low-grade cerebral gliomas: Analysis of results in a series of 36 cases, Acta Neurochirurgica, vol.99, issue.Suppl, pp.97-105, 1994. ,
DOI : 10.1007/978-3-642-68178-3_1
Survival after stereotactic biopsy and irradiation of cerebral nonanaplastic, nonpilocytic astrocytoma, Journal of Neurosurgery, vol.3, issue.4, pp.523-529, 1995. ,
DOI : 10.1016/0360-3016(90)90397-3
Low-grade astrocytoma: treatment with conventionally fractionated stereotactic radiation therapy., Radiology, vol.201, issue.1, pp.275-278, 1996. ,
DOI : 10.1148/radiology.201.1.8816559
Quality of life self-reports from 200 brain tumor patients: comparisons with Karnofsky performance scores, Journal of Neuro-Oncology, vol.14, issue.3, pp.243-253, 1992. ,
DOI : 10.1007/BF00172600
Assessment of quality of life in patients treated for low-grade glioma: a preliminary report., Journal of Neurology, Neurosurgery & Psychiatry, vol.55, issue.5, pp.372-376, 1992. ,
DOI : 10.1136/jnnp.55.5.372
Cognitive functions and quality of life in patients with low-grade gliomas: The impact of radiotherapy, Annals of Neurology, vol.47, issue.1, pp.48-54, 1994. ,
DOI : 10.1001/archneur.1990.00530040039017
Quality of life in patients with glioblastoma participating in a randomized study of boost brachytherapy, Journal of Neurosurgery, vol.45, issue.6, pp.917-926, 2000. ,
DOI : 10.1002/1097-0142(19800415)45:8<2220::AID-CNCR2820450835>3.0.CO;2-Q
Prospective Study of Quality of Life in Adults with Newly Diagnosed High-grade Gliomas, Journal of Neuro-Oncology, vol.2, issue.Suppl 1, pp.283-291, 2006. ,
DOI : 10.4088/JCP.v61n0608
Prospective assessment of quality of life in adult patients with primary brain tumors in routine neurooncology practice, Journal of Neuro-Oncology, vol.90, issue.3, pp.413-419, 2009. ,
DOI : 10.1007/s11060-009-9810-y
Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors, International Journal of Radiation Oncology*Biology*Physics, vol.55, issue.4, pp.992-999, 2003. ,
DOI : 10.1016/S0360-3016(02)04205-0
Quality of life in low-grade glioma patients receiving temozolomide, Neuro-Oncology, vol.11, issue.1, pp.59-68, 2009. ,
DOI : 10.1023/A:1023900802254
Health-Related Quality of Life in Patients Treated With Temozolomide Versus Procarbazine for Recurrent Glioblastoma Multiforme, Journal of Clinical Oncology, vol.18, issue.7, pp.1481-1491, 2000. ,
DOI : 10.1200/JCO.2000.18.7.1481
Quality of life among patients with a brain tumor and their carers, Journal of Psychosomatic Research, vol.63, issue.6, pp.617-623, 2007. ,
DOI : 10.1016/j.jpsychores.2007.06.018
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology, JNCI Journal of the National Cancer Institute, vol.85, issue.5, pp.365-376, 1993. ,
DOI : 10.1093/jnci/85.5.365
The relationship between function, quality of life and coping in patients with low-grade gliomas, Supportive Care in Cancer, vol.111, issue.6, pp.1205-1212, 2006. ,
DOI : 10.7326/0003-4819-111-6-517
Quality of life and seizure control in patients with brain tumor-related epilepsy treated with levetiracetam monotherapy: preliminary data of an open-label study, Neurological Sciences, vol.5, issue.4, 2009. ,
DOI : 10.1001/archinte.1951.03810040002001
Decreased quality of life and depression as predictors for shorter survival among patients with low-grade gliomas: a follow-up from 1990 to 2003, European Archives of Psychiatry and Clinical Neuroscience, vol.76, issue.5, pp.516-521, 1990. ,
DOI : 10.1111/j.1532-5415.2000.tb03886.x
Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues, Journal of Neuro-Oncology, vol.57, issue.1, pp.41-49, 2002. ,
DOI : 10.1023/A:1015728825642
Fatigue in low-grade glioma, Journal of Neuro-Oncology, vol.256, issue.1, pp.73-78, 2009. ,
DOI : 10.1038/bjc.1998.600
A new tool for grade??II glioma studies: plotting cumulative time with quality of life versus time to malignant transformation, Journal of Neuro-Oncology, vol.4, issue.1, 2011. ,
DOI : 10.1007/BF00172600
Pitfalls in the Assessment of Disability in Individuals with Low-Grade Gliomas, Journal of Neuro-Oncology, vol.65, issue.2, pp.149-158, 2003. ,
DOI : 10.1023/B:NEON.0000003727.09448.dd
Late recurrence of primitive neuroectodermal Tumor/Medulloblastoma, Cancer, vol.60, issue.4, pp.826-830, 1988. ,
DOI : 10.1001/archneur.1975.00490530053004
Seizure control: A secondary benefit of chemotherapeutic temozolomide in brain cancer patients, Epilepsy Research, vol.95, issue.3, 2011. ,
DOI : 10.1016/j.eplepsyres.2011.03.018
Medically Intractable Epilepsy from Insular Low-Grade Gliomas: Improvement after an Extended Lesionectomy, Acta Neurochirurgica, vol.144, issue.6, pp.563-572, 2002. ,
DOI : 10.1007/s00701-002-0941-6
Predictors of seizure freedom after resection of supratentorial low-grade gliomas, Journal of Neurosurgery, vol.18, issue.2, 2011. ,
DOI : 10.1097/00006123-199708000-00008
Epileptic seizures and survival in early disease of grade 2 gliomas, European Journal of Neurology, vol.39, issue.7, pp.823-831, 2009. ,
DOI : 10.1016/S1052-5149(03)00090-X
Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors, Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, vol.54, pp.1886-1893, 2000. ,
Epilepsy in low-grade gliomas: The impact on cognitive function and quality of life, Annals of Neurology, vol.342, issue.4, pp.514-520, 2003. ,
DOI : 10.1056/NEJM200002033420503
Cognition and health-related quality of life in a well-defined subgroup of patients with partial epilepsy, Journal of Neurology, vol.249, issue.3, pp.294-299, 2002. ,
DOI : 10.1007/s004150200008
Brain tumors and epilepsy, Expert Review of Neurotherapeutics, vol.14, issue.6, pp.941-955, 2008. ,
DOI : 10.1093/annonc/mdg502
Seizures in low- and high-grade gliomas: current management and future outlook, Expert Review of Anticancer Therapy, vol.14, issue.5, pp.663-669, 2010. ,
DOI : 10.1093/annonc/mdg502
Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide, Neuro-Oncology, vol.7, issue.5, pp.917-927, 2010. ,
DOI : 10.1093/carcin/20.12.2361
URL : https://academic.oup.com/neuro-oncology/article-pdf/12/9/917/16662992/noq044.pdf
Contrasting acute and slow-growing lesions: a new door to brain plasticity, Brain, vol.130, issue.4, pp.898-914, 2007. ,
DOI : 10.1093/brain/awl300
URL : https://hal.archives-ouvertes.fr/inserm-00164411
Gliomes de bas grade et plasticit?? c??r??brale, m??decine/sciences, vol.22, issue.4, pp.389-394, 2006. ,
DOI : 10.1051/medsci/2006224389
URL : http://www.medecinesciences.org/articles/medsci/pdf/2006/05/medsci2006224p389.pdf
Functional recuperation after resection of gliomas infiltrating primary somatosensory fields. Study of perioperative electric stimulation], Neurochirurgie, vol.47, pp.534-541, 2001. ,
Somatotopy of the supplementary motor area: evidence from correlation of the extent of surgical resection with the clinical patterns of deficit, Neurosurgery, vol.50, pp.297-303, 2002. ,
The insular lobe and brain plasticity: Lessons from tumor surgery, Clinical Neurology and Neurosurgery, vol.108, issue.6, pp.543-548, 2006. ,
DOI : 10.1016/j.clineuro.2005.09.004
URL : https://hal.archives-ouvertes.fr/inserm-00163816
Functional recovery after surgical resection of low grade gliomas in eloquent brain: hypothesis of brain compensation, Journal of Neurology, Neurosurgery & Psychiatry, vol.74, issue.7, pp.901-907, 2003. ,
DOI : 10.1136/jnnp.74.7.901
Absence of movement disorders after resection of glioma invading the right striatum, Journal of Neurosurgery, vol.152, issue.2, pp.363-369, 2002. ,
DOI : 10.1097/00006123-199801000-00005
Long term reshaping of language, sensory, and motor maps after glioma resection: a new parameter to integrate in the surgical strategy, J Neurol Neurosurg Psychiatry, vol.72, pp.511-516, 2002. ,
Long-term brain plasticity allowing a multistage surgical approach to World Health Organization Grade II gliomas in eloquent areas, Journal of Neurosurgery, vol.79, issue.4, pp.615-624, 2008. ,
DOI : 10.1161/01.STR.0000174487.81126.ef
Does post-lesional subcortical plasticity exist in the human brain?, Neuroscience Research, vol.65, issue.2, pp.131-135, 2009. ,
DOI : 10.1016/j.neures.2009.07.002
Evidence for potentials and limitations of brain plasticity using an atlas of functional resectability of WHO grade II gliomas: Towards a ???minimal common brain???, NeuroImage, vol.56, issue.3, pp.992-1000, 2011. ,
DOI : 10.1016/j.neuroimage.2011.03.022
From hodology to function, Brain, vol.54, issue.6, pp.602-605, 2007. ,
DOI : 10.1002/mrm.20642
Computational modeling of the WHO grade II glioma dynamics: principles and applications to management paradigm, Neurosurgical Review, vol.20, issue.6, pp.263-269, 2008. ,
DOI : 10.1016/S0028-3770(05)83486-1
Functional mapping-guided resection of low-grade gliomas, Clin Neurosurg, vol.42, pp.437-452, 1995. ,
Intraoperative cortico???subcortical stimulations in surgery of low-grade gliomas, Expert Review of Neurotherapeutics, vol.12, issue.4, pp.473-485, 2005. ,
DOI : 10.1097/00001756-200107200-00023
Contribution of cortical and subcortical electrostimulation in brain glioma surgery: Methodological and functional considerations, Neurophysiologie Clinique/Clinical Neurophysiology, vol.37, issue.6, pp.373-382, 2007. ,
DOI : 10.1016/j.neucli.2007.09.003
Predicting lung cancer by detecting aberrant promoter methylation in sputum, Cancer Res, vol.60, pp.5954-5958, 2000. ,
Analysis of the IDH1 codon 132 mutation in brain tumors, Acta Neuropathologica, vol.6, issue.6, pp.597-602, 2008. ,
DOI : 10.1093/jnen/59.6.544
mutations in Japanese glioma patients, Cancer Science, vol.324, issue.10, pp.1996-1998, 2009. ,
DOI : 10.1016/B978-0-12-152827-0.50009-8